Search clinical trials for: Anagliptin BID Treatment

Total 15275 results

University of Alabama at Birmingham
Patient-Centered Outcomes Research Institute

Active, not recruiting

Implementing the Decision-Aid for Lupus (IDEAL Strategy) (IDEAL)

Systemic Lupus Erythematosus

United States
University of Illinois at Chicago
Laura and John Arnold Foundation; Big Brothers Big Sisters of America; Herrera... and other collaborators

Active, not recruiting

Randomized Controlled Trial of Big Brothers Big Sisters Mentoring for Prevention of Crime and Delinquency

Juvenile Delinquency | Crime

United States
University of Pennsylvania

Completed

Impact of Anticipated Regret Incorporation Into Patient Decision Aids

Regret
Cliniques universitaires Saint-Luc- Université...

Completed

Surgical Treatment of Mandibular Furcations Using a Xenograft With/Without a Collagen Membrane

Furcation Defects
Arog Pharmaceuticals, Inc.

Completed

Study of Crenolanib for the Treatment of Patients With Advanced GIST With the D842-related Mutations and Deletions in the PDGFRA Gene

D842-related Mutant GIST

United States
Fayoum University
Boehringer Ingelheim

Completed

Contrast Nephropathy in Type 2 Diabetes (VCG4)

Diabetes | Microalbuminuria | Kidney Function Affection Upon Exposure to Radiocontrast

Egypt
Shanghai Zhongshan Hospital
Chinese Medical Association

Completed

Study About Effect of Saxagliptin on Circulating Endothelial Progenitor Cells and Endothelial Function in Newly Diagnosed Type 2 Diabetic Patients

Type 2 Diabetes Mellitus

China
yangjie

Completed

Thrombocytopoiesis and Platelet Homeostasis in Infants With Bronchoplumonary Dysplasia (BPD)

Thrombocytopenia | Bronchopulmonary Dysplasia | Preterm Infant

China
Biogen

Terminated

Study of Natalizumab in Relapsed/Refractory Multiple Myeloma

Multiple Myeloma

United States
Biogen

Completed

New Formulation and Food Effect Study of BIIB074

Trigeminal Neuralgia (TN) | Other Neuropathic Pain

United States
Boehringer Ingelheim
Eli Lilly and Company

Completed

A 16 Weeks Study on Efficacy and Safety of Two Doses of Empagliflozin (BI 10773) (Once Daily Versus Twice Daily) in Patients With Type 2 Diabetes Mellitus and Preexisting Metformin Therapy

Diabetes Mellitus, Type 2

United States, Australia, Canada, Estonia, France, Georgia, Germany, Guatemala, Italy, Latvia, Lithuania, Mexico, New Zealand, Poland, Russian Federation, South Africa, Spain, Ukraine
Uppsala University

Completed

Survival After Surgical Treatment of Axis Fractures in Elderly

Spinal Fractures
Heidelberg University

Completed

Anesthetic Depth Effects Upon Immune Competent Cells (BIS-MA)

Anesthesia | Immunotoxicity | Inert Gas Narcosis

Germany
Long Min,MD

Unknown

Dipeptidyl Peptidase 4 Inhibition Facilitate Healing of Diabetic Ulcers (DPP4i)

Diabetic Foot Ulcer

China
Boehringer Ingelheim
Eli Lilly and Company

Completed

MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptin

Diabetes Mellitus, Type 2

Germany, Spain, United States, Canada, Taiwan, Korea, Republic of, Finland, Denmark, France, Japan, Philippines, Vietnam
Fourth People's Hospital of Shenyang

Completed

The Effect of Alogliptin on Pulmonary Function in Obese Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy

Diabetes Mellitus, Type 2
Boehringer Ingelheim

Completed

Bioequivalence of a Linagliptin / Metformin Fixed-dose Combination (FDC) Tablet Compared With Single Linagliptin and Metformin Tablets Administered Together in Healthy Volunteers

Healthy
Boehringer Ingelheim

Completed

Bioequivalence of a 2.5 mg Linagliptin / 850 mg Metformin Fixed Dose Combination Tablet Compared With Single Linagliptin 2.5 mg and Metformin 850 mg Tablets in Healthy Volunteers

Healthy
Boehringer Ingelheim

Completed

Bioequivalence of Metformin Under Fed Conditions After Administration of Linagliptin / Metformin Fixed Dose Combination Tablet and Single Tablets

Healthy

Germany
vTv Therapeutics

Not yet recruiting

Cadisegliatin as Adjunctive Therapy in Type 1 Diabetes (CATT1)

Diabetes Mellitus, Type 1
Pinnacle Clinical Research, PLLC

Completed

An Evaluation of the Safety and Efficacy of Nitazoxanide on Collagen Turnover in NASH Patients With Fibrosis

Fatty Liver | Fibrosis, Liver | Compensated Cirrhosis | Non-alcoholic Steatohepatitis

United States
Cornerstone Pharmaceuticals

Withdrawn

Safety and Effectiveness Study of CPI-613 to Treat Refractory or Relapsed Leukemia and Myelodysplastic Syndrome

Acute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)

United States
Karolinska Institutet
Karolinska University Hospital; Umeå University; Leiden University; Dalarna University and other collaborators

Recruiting

Development, Implementation and Evaluation of an Individual Decision Aid in Swedish Cancer Screening Programs (BESTa)

Neoplasm, Breast | Neoplasm, Colorectal | Neoplasm, Ovarian

Sweden
GID BIO, Inc.

Not yet recruiting

Adipose-derived SVF for Treatment of Erectile Dysfunction (ED)

Erectile Dysfunction

United States
Education University of Hong Kong
Chinese University of Hong Kong

Completed

Efficacy of Amplification With Hearing Aids for Tinnitus Relief

Tinnitus, Subjective | Hearing Impairment

Hong Kong
Altamira Medica Ltd.

Completed

Efficacy and Safety of AM-301 on Allergic Symptoms of Perennial Allergic Rhinitis Sufferers

Rhinitis, Allergic | Perennial Allergic Rhinitis

Canada
Brainsway

Completed

Evaluation of Deep Transcranial Magnetic Stimulation (DTMS) With the H-ADD Coil as an Aid to Smoking Cessation.

Smoking Cessation

United States, Canada, Israel
University of Thessaly

Recruiting

The Impact of the Implementation of BIS on the Incidence of Postoperative Delirium

Postoperative Delirium

Greece
St. Joseph's Healthcare Hamilton

Completed

Brief Intervention and Contact (BIC) Program (BIC)

Suicidal Behavior

Canada
Mahidol University

Completed

BIA-Guided Dry Weight Assessment on Sleep Quality in Chronic Hemodialysis Patients (BEDTIME)

Renal Failure Chronic Requiring Hemodialysis | Poor Quality Sleep

Thailand
JW Pharmaceutical

Active, not recruiting

Korean Observational Study to Evaluate the Efficacy and Safety of Anagliptin Switching From Other DPP4is in type2 DM (SSUG)

Type 2 Diabetes Mellitus

Korea, Republic of
Eisai Inc.

Completed

BLOSSOM: Behavioral Modification and Lorcaserin Second Study for Obesity Management

Obesity

United States
Pfizer

Completed

A Study Estimating The Time Course Of PF-04764793 In The Blood Following Dosing By Oral Inhalation From Dry Powder Inhalers

Healthy

Singapore
BDH-Klinik Hessisch Oldendorf

Recruiting

Influence of the Body Composition of Neurological (Early) Rehabilitants on Rehabilitation Success

Neurological Rehabilitation

Germany
Klinikum St. Georg gGmbH

Completed

Malnutrition Using GLIM Criteria and Comparing CT and BIA for Muscle Mass Measurement

Malnutrition
Samsung Medical Center

Completed

Bispectral Index Throughout Esophageal Cancer Operation

Esophageal Cancer

Korea, Republic of
Takeda

Completed

A Study for Post-Marketing Surveillance of Nesina® Tablet Monotherapy or Combination Therapy in Participants With Type 2 Diabetes (T2DM) in South Korea

Type 2 Diabetes Mellitus

Korea, Republic of
Rabin Medical Center

Terminated

Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19

Glucose Metabolism Disorders | Respiratory Tract Diseases | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Endocrine System Diseases | COVID 19 | Coronavirus | Metabolic Disease | Severe Acute Respiratory Syndrome Coronavirus 2 | Sars-CoV2 | Hormones | Hypoglycemic Agents | Incretins | Dipeptidyl-Peptidase IV Inhibitors and other conditions

Israel
Takeda

Completed

An Observational Study of Alogliptin Benzoate in Participants With Diabetes Mellitus Type 2

Diabetes Mellitus

Russian Federation
Assistance Publique - Hôpitaux de Paris

Completed

ACute and Chronic Effects of Saxagliptin (ACCES)

Impaired Glucose Tolerance

France
CEU San Pablo University

Unknown

Upper Limb Intensive Therapies in Babies With Unilateral Cerebral Palsy.

Upper Extremity Paresis | Family | Infantile Hemiplegia | Constraint Induced Movement Therapy | Bimanual Intensive Therapy

Spain
University of Tromso
Norway: Helgeland Hospital

Withdrawn

Better First Aid With First Aid Training and Dispatcher Central Instructions?

Injury

Norway
EMS

Not yet recruiting

Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes Mellitus

Type 2 Diabetes Mellitus
University of Pisa

Completed

Effects of Dapagliflozin+Saxagliptin in Addition to Metformin v/s Saxagliptin or Dapagliflozin in Patients With DM2.

Type2 Diabetes Mellitus

Italy
Boehringer Ingelheim
Eli Lilly and Company

Completed

Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Japanese Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Japan
AstraZeneca

Completed

Evaluate the Efficacy and Safety of Saxagliptin in Combination With Metformin IR Compared to Saxagliptin Monotherapy and to Metformin IR Monotherapy in Drug Naive Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control

Type 2 Diabetes Mellitus

China
Stanford University

Not yet recruiting

Examining Bluetooth Haptic Device Use for Pain and Anxiety Reduction in Vascular Access Procedures (VA+BHD)

Pain | Anxiety
Biocad

Recruiting

A Clinical Study of BCD-217 (Nurulimab + Prolgolimab) Followed by Anti-PD-1 Compared to Anti-PD-1 Monotherapy as First-Line Treatment in Subjects With Unresectable/Metastatic Melanoma (OCTAVA)

Melanoma | Melanoma (Skin) | Melanoma Stage IV | Melanoma Stage III | Melanoma Metastatic | Melanoma Unresectable | Melanoma Advanced

India, Russian Federation, Belarus
KU Leuven
Universitaire Ziekenhuizen KU Leuven

Recruiting

Locomotor Muscle Oxygenation and Activation During Acute Interval Compared to Constant-load Bed-cycling Exercise

Critical Illness | Intensive Care Unit Acquired Weakness

Belgium
Biocad

Active, not recruiting

Study of Efficacy and Safety of BCD-217 (Anti-CTLA-4 and Anti-PD-1) Followed By BCD-100 (Anti-PD-1) Versus BCD-100 Monotherapy as First-Line Treatment in Patients With Unresectable or Metastatic Melanoma (OBERTON)

Melanoma | Melanoma Metastatic

Russian Federation, Belarus

3

Subscribe